At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 30 enrolled
Drug / intervention
Benazepril +1 moredrug
Likely dose
Benazepril 20 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Comparison Between Losartan and Benazepril in Diabetic Hypertensive Patients With Blood Pressure Not Controlled by Amlodipine: Effects on Echocardiographic Parameters, Vascular Stiffness and Endothelial Function.
In Brief
A Phase 4 clinical trial evaluating Benazepril and Losartan for Hypertension and Diabetes Mellitus. Completed, enrolled 30 participants across 1 site.
Detailed Summary
The purpose of this study is to compare losartan and benazepril in diabetic patients whose high blood pressure is not controlled by amlodipine and its relationship to statin current use.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypertension, Diabetes Mellitus
CountriesBrazil
Collaborators--
Timeline
Phase 4CompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartMay 2012
First PostedMay 2012
Primary CompletionJan 2015
TodayJul 2026
First PostedMay 23, 2012
Enrollment StartMay 1, 2012
Primary CompletionJan 1, 2015
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 14.1 years ago
Interventions
Benazeprildrug
Patients in this group will receive 20 mg of benazepril per day, orally, during 12 weeks.
Losartandrug
Patients in this group will receive 100 mg of losartan per day, orally, during 12 weeks.